Biotech News

Valneva to Participate at U.S. and European Investor Conferences in June - Valneva

Valneva (VLA)Valneva2026-05-28 15:48 ESTConference / presentation

May 28, 2026

Lyon ( France), May 28 , 202 6 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several up coming investor conferences in the United States and Europe in June 202 6 .

To access the full release, please click on the PDF below.

Press Release

Open original release

Related news

VLAValneva2026-06-25 15:45 EST

Valneva Announces Successful Outcome of its Annual General Meeting - Valneva

VLAValneva2026-06-19 13:15 EST

Valneva Press Releases | Latest Company News & Updates

VLAValneva2026-06-19 13:15 EST

Valneva Press Releases | Latest Company News & Updates

VLAValneva2026-06-04 12:13 EST

Valneva Announces Availability of Documentation for its Annual General Meeting - Valneva

USNAUsana Health Sciences, Inc.2026-07-14 20:15 EST

USANA Schedules Second Quarter 2026 Earnings Release and Conference Call

VANIVivani Medical2026-07-14 20:03 EST

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

XOMAXOMA Corporation2026-07-14 13:00 EST

XOMA Royalty Announces Closing of Its Acquisition by Ligand

ARTLArtelo Biosciences2026-07-14 12:47 EST

Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026

ICCMIceCure Medical2026-07-14 12:32 EST

IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation

ZBHZimmer Biomet2026-07-14 12:13 EST

Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

View all latest news

Valneva

Valneva is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

VLAZimmer Biomet2026-07-14 12:13 EST

Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

VLAZimmer Biomet2026-07-13 12:14 EST

Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results

VLABMYBristol-Myers Squibb Company2026-07-13 10:59 EST

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

VLAGSK plc2026-07-13 07:00 EST

Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

VLAMerck2026-07-10 19:01 EST

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States